Regulation of the apolipoprotein gene cluster by a long noncoding RNA

Cell Reports

Volumn 6, Issue 1, 2014, Pages 222-230

  Halley, Paul ^a   Kadakkuzha, BeenaM ^a   Faghihi, MohammadAli ^a   Magistri, Marco ^a   Zeier, Zane ^a   Khorkova, Olga ^b   Coito, Carlos ^b   Hsiao, Jane ^b   Lawrence, Matthew ^c   Wahlestedt, Claes ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b OPKO Health Inc   (United States)

^c RxGen Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; LONG UNTRANSLATED RNA;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOA1 GENE; APOLIPOPROTEIN GENE; ARTICLE; CHLOROCEBUS AETHIOPS; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA FLANKING REGION; FEMALE; GENE CLUSTER; GENE EXPRESSION REGULATION; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; TRANSCRIPTION REGULATION; UPREGULATION;

CERCOPITHECUS AETHIOPS;

ANIMALS; APOLIPOPROTEIN A-I; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; HEP G2 CELLS; HEPATOCYTES; HISTONES; HUMANS; METHYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, ANTISENSE; RNA, LONG NONCODING; VERO CELLS;

EID: 84892529760     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.12.015     Document Type: Article

References (47)

1. Adamo A., Sesé B., Boue S., Castaño J., Paramonov I., Barrero M.J., Izpisua Belmonte J.C. LSD1 regulates the balance between self-renewal and differentiation in human embryonic stem cells. Nat. Cell Biol. 2011, 13:652-659.
2. Ansari A.Z. Riboactivators: transcription activation by noncoding RNA. Crit. Rev. Biochem. Mol. Biol. 2009, 44:50-61.
3. Antonarakis S.E., Oettgen P., Chakravarti A., Halloran S.L., Hudson R.R., Feisee L., Karathanasis S.K. DNA polymorphism haplotypes of the human apolipoprotein APOA1-APOC3-APOA4 gene cluster. Hum. Genet. 1988, 80:265-273.
4. Barbaras R., Puchois P., Fruchart J.C., Ailhaud G. Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles. Biochem. Biophys. Res. Commun. 1987, 142:63-69.
5. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6:857-866.
6. Camblong J., Iglesias N., Fickentscher C., Dieppois G., Stutz F. Antisense RNA stabilization induces transcriptional gene silencing via histone deacetylation in S. cerevisiae. Cell 2007, 131:706-717.
7. Cao R., Wang L., Wang H., Xia L., Erdjument-Bromage H., Tempst P., Jones R.S., Zhang Y. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 2002, 298:1039-1043.
8. Dias N., Stein C.A. Antisense oligonucleotides: basic concepts and mechanisms. Mol. Cancer Ther. 2002, 1:347-355.
9. Eisenberg S. High density lipoprotein metabolism. J.Lipid Res. 1984, 25:1017-1058.
10. Elshourbagy N.A., Boguski M.S., Liao W.S., Jefferson L.S., Gordon J.I., Taylor J.M. Expression of rat apolipoprotein A-IV and A-I genes: mRNA induction during development and in response to glucocorticoids and insulin. Proc. Natl. Acad. Sci. USA 1985, 82:8242-8246.
11. Faghihi M.A., Wahlestedt C. Regulatory roles of natural antisense transcripts. Nat. Rev. Mol. Cell Biol. 2009, 10:637-643.
12. Faghihi M.A., Kocerha J., Modarresi F., Engström P.G., Chalk A.M., Brothers S.P., Koesema E., St Laurent G., Wahlestedt C. RNAi screen indicates widespread biological function for human natural antisense transcripts. PLoS ONE 2010, 5:e13177.
13. Glomset J.A. The plasma lecithins:cholesterol acyltransferase reaction. J.Lipid Res. 1968, 9:155-167.
14. Green P.H., Glickman R.M., Saudek C.D., Blum C.B., Tall A.R. Human intestinal lipoproteins. Studies in chyluric subjects. J.Clin. Invest. 1979, 64:233-242.
15. Guttman M., Donaghey J., Carey B.W., Garber M., Grenier J.K., Munson G., Young G., Lucas A.B., Ach R., Bruhn L., et al. lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 2011, 477:295-300.
16. Huarte M., Guttman M., Feldser D., Garber M., Koziol M.J., Kenzelmann-Broz D., Khalil A.M., Zuk O., Amit I., Rabani M., et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 2010, 142:409-419.
17. Kaikkonen M.U., Lam M.T.Y., Glass C.K. Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovasc. Res. 2011, 90:430-440.
18. Katayama S., Tomaru Y., Kasukawa T., Waki K., Nakanishi M., Nakamura M., Nishida H., Yap C.C., Suzuki M., Kawai J., et al. Antisense transcription in the mammalian transcriptome. Science 2005, 309:1564-1566. RIKEN Genome Exploration Research Group, Genome Science Group (Genome Network Project Core Group)Genome Science Group (Genome Network Project Core Group), FANTOM ConsortiumFANTOM Consortium.
19. Kim T.H., Abdullaev Z.K., Smith A.D., Ching K.A., Loukinov D.I., Green R.D., Zhang M.Q., Lobanenkov V.V., Ren B. Analysis of the vertebrate insulator protein CTCF-binding sites in the human genome. Cell 2007, 128:1231-1245.
20. Kotake Y., Nakagawa T., Kitagawa K., Suzuki S., Liu N., Kitagawa M., Xiong Y. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene 2011, 30:1956-1962.
21. Kouzarides T. Histone methylation in transcriptional control. Curr. Opin. Genet. Dev. 2002, 12:198-209.
22. Kuzmichev A., Nishioka K., Erdjument-Bromage H., Tempst P., Reinberg D. Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. Genes Dev. 2002, 16:2893-2905.
23. LeCluyse E.L., Alexandre E., Hamilton G.A., Viollon-Abadie C., Coon D.J., Jolley S., Richert L. Isolation and culture of primary human hepatocytes. Methods Mol. Biol. 2005, 290:207-229.
24. Lehner B., Williams G., Campbell R.D., Sanderson C.M. Antisense transcripts in the human genome. Trends Genet. 2002, 18:63-65.
25. Livshits G., Vainder M., Graff E., Blettner M., Schettler G., Brunner D. Tel-Aviv-Heidelberg Three Generation Offspring Study: genetic and environmental sources of variation and covariation among plasma lipids, lipoproteins, and apoliproteins. Am. J. Hum. Biol. 1997, 9:357-370.
26. Magistri M., Faghihi M.A., St Laurent G., Wahlestedt C. Regulation of chromatin structure by long noncoding RNAs: focus on natural antisense transcripts. Trends Genet. 2012, 28:389-396.
27. Martinho R.G., Kunwar P.S., Casanova J., Lehmann R. A noncoding RNA is required for the repression of RNApolII-dependent transcription in primordial germ cells. Curr. Biol. 2004, 14:159-165.
28. McDermott A.M., Heneghan H.M., Miller N., Kerin M.J. The therapeutic potential of microRNAs: disease modulators and drug targets. Pharm. Res. 2011, 28:3016-3029.
29. Miller B.H., Wahlestedt C. MicroRNA dysregulation in psychiatric disease. Brain Res. 2010, 1338:89-99.
30. Mishiro T., Ishihara K., Hino S., Tsutsumi S., Aburatani H., Shirahige K., Kinoshita Y., Nakao M. Architectural roles of multiple chromatin insulators at the human apolipoprotein gene cluster. EMBO J. 2009, 28:1234-1245.
31. Modarresi F., Faghihi M.A., Lopez-Toledano M.A., Fatemi R.P., Magistri M., Brothers S.P., van der Brug M.P., Wahlestedt C. Inhibition of natural antisense transcripts invivo results in gene-specific transcriptional upregulation. Nat. Biotechnol. 2012, 30:453-459.
32. Nagano T., Mitchell J.A., Sanz L.A., Pauler F.M., Ferguson-Smith A.C., Feil R., Fraser P. The Air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science 2008, 322:1717-1720.
33. Pastori C., Wahlestedt C. Involvement of long noncoding RNAs in diseases affecting the central nervous system. RNA Biol. 2012, 9:860-870.
34. Rader D.J. High-density lipoproteins and atherosclerosis. Am. J. Cardiol. 2002, 90(8A):62i-70i.
35. Rinn J.L., Kertesz M., Wang J.K., Squazzo S.L., Xu X., Brugmann S.A., Goodnough L.H., Helms J.A., Farnham P.J., Segal E., Chang H.Y. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007, 129:1311-1323.
36. Shi Y., Lan F., Matson C., Mulligan P., Whetstine J.R., Cole P.A., Casero R.A., Shi Y. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004, 119:941-953.
37. Sleutels F., Zwart R., Barlow D.P. The non-coding Air RNA is required for silencing autosomal imprinted genes. Nature 2002, 415:810-813.
38. Stavropoulos P., Blobel G., Hoelz A. Crystal structure and mechanism of human lysine-specific demethylase-1. Nat. Struct. Mol. Biol. 2006, 13:626-632.
39. Strahl B.D., Allis C.D. The language of covalent histone modifications. Nature 2000, 403:41-45.
40. Taft R.J., Pang K.C., Mercer T.R., Dinger M., Mattick J.S. Non-coding RNAs: regulators of disease. J.Pathol. 2010, 220:126-139.
41. Tsai M.C., Manor O., Wan Y., Mosammaparast N., Wang J.K., Lan F., Shi Y., Segal E., Chang H.Y. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010, 329:689-693.
42. van Rooij E., Olson E.N. MicroRNAs: powerful new regulators ofheart disease and provocative therapeutic targets. J.Clin. Invest. 2007, 117:2369-2376.
43. Veedu R.N., Wengel J. Locked nucleic acid as a novel class of therapeutic agents. RNA Biol. 2009, 6:321-323.
44. Wahlestedt C. Natural antisense and noncoding RNA transcripts as potential drug targets. Drug Discov. Today 2006, 11:503-508.
45. Wang J., Lu F., Ren Q., Sun H., Xu Z., Lan R., Liu Y., Ward D., Quan J., Ye T., Zhang H. Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties. Cancer Res. 2011, 71:7238-7249.
46. Wang K.C., Yang Y.W., Liu B., Sanyal A., Corces-Zimmerman R., Chen Y., Lajoie B.R., Protacio A., Flynn R.A., Gupta R.A., et al. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 2011, 472:120-124.
47. Zamore P.D., Tuschl T., Sharp P.A., Bartel D.P. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 2000, 101:25-33.